ABOUT ME

After working as a scientist in cancer research for eight years, I decided to switch gears and start a career as a medical writer. I am passionate about helping research groups translate new research findings into treatments for patients.

Please see below for an overview of my experience.

Education

PhD Tumor Immunology.
University of Groningen, Groningen, The Netherlands

Nov 2011- Mar 2016

MSc Human Pathobiology & Toxicology.
Radboud University Nijmegen, Nijmegen, The Netherlands.

Sep 2009 - Aug 2011

BSc Biomedical Sciences.
Radboud University Nijmegen, Nijmegen, The Netherlands.

Sep 2005 - Aug 2009

Work Experience

Freelance Medical and Science Writer and Editor

Wouters Writing, Victoria, BC, Canada

January 2020 - Present

Postdoctoral Research Fellow Cancer Immunotherapy

BC Cancer, Victoria, BC, Canada

March 2016 - December 2019

PhD Researcher Tumor Immunology

University Medical Centre Groningen, the Netherlands

November 2011 -November 2015

Publications

Peer-reviewed journal articles

Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer

The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

A transcriptionally distinct CXCL13+CD103+CD8+ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer

Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer

Online Articles and Blogs

wouterswriting.contently.com

proudmember2021.jpg
HealthWriterHubAlumniLogo-whitebackgroun